Shukra Pharma. Q1 FY27 Results (NSE: SHUKRAPHAR)

· Analysis by Alpha Inflection

Signal: Margins at cyclical peak

Shukra Pharma. Q1 FY27 key financials
MetricValueYoYQoQ
Revenue₹23.52 Cr+336.4%+272.0%
EBIT₹18.6 Cr+1033.5%
Net profit₹12.96 Cr+1159.3%
EPS₹0.3+1400.0%
EBIT margin83.68%

P&L walk

Revenue rebounded to ₹2352.23 lakh, +336.4% YoY and +272.0% QoQ, driving EBIT of ₹1860.13 lakh and EBITDA margin of 83.68%; employee costs rose +140.5% YoY but much slower than revenue, supporting substantial fixed-cost absorption, while PAT of ₹1295.85 lakh was operating-led despite other income falling 51.4%.

View original filing

Research and educational content only. Not investment advice.